BCL2 and diffuse large B-cell lymphoma: High levels of BCL-2 and/or BCL-2 “dependence” are observed in patients with follicular lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, and adult leukemias, and BCL-2 inhibition in patients with these diagnoses has led to promising treatment results [15,16,17,18,19].